{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:24:22Z","timestamp":1792167862404,"version":"4.4.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.pan.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T16:25:14Z","timestamp":1653668714000},"page":"719-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines"],"prefix":"10.1016","volume":"22","author":[{"given":"Cade","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Suguitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3122-6873","authenticated-orcid":false,"given":"Akhil","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2022.05.005_bib1","series-title":"CancerNet","author":"Pancreatic Cancer - Statistics","year":"2012"},{"key":"10.1016\/j.pan.2022.05.005_bib2","unstructured":"Cancer of the pancreas - cancer stat facts. SEER."},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib4","first-page":"196","article-title":"Hereditary vs familial pancreatic cancer: associated genetic syndromes and clinical perspective","volume":"34","author":"Copur","year":"2020","journal-title":"Oncology"},{"issue":"43","key":"10.1016\/j.pan.2022.05.005_bib5","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.pan.2022.05.005_bib6","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2015.07.057","article-title":"Genetics and genetic testing in pancreatic cancer","volume":"149","author":"Whitcomb","year":"2015","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.pan.2022.05.005_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/MPA.0000000000001136","article-title":"Germline variants and risk for pancreatic cancer: a systematic review and emerging concepts","volume":"47","author":"Zhan","year":"2018","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.pan.2022.05.005_bib10","series-title":"GeneReviews\u00ae","article-title":"BRCA1- and BRCA2-associated hereditary breast and ovarian cancer","author":"Petrucelli","year":"1993"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"10.1016\/j.pan.2022.05.005_bib12","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.pan.2022.05.005_bib13","first-page":"1358","article-title":"Cancer incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"CancerSpect KnowlEnviron"},{"issue":"2","key":"10.1016\/j.pan.2022.05.005_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4143\/crt.2016.217","article-title":"The prevalence of founder mutations among individuals from families with familial pancreatic cancer syndrome","volume":"49","author":"Lener","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.pan.2022.05.005_bib15","article-title":"Multigene hereditary cancer panels reveal high-risk pancreatic cancer susceptibility genes","volume":"2","author":"Hu","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"8","key":"10.1016\/j.pan.2022.05.005_bib16","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamaoncol.2020.2134","article-title":"Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants: results from the consortium of investigators of modifiers of BRCA1\/2 (CIMBA)","volume":"6","author":"Silvestri","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.pan.2022.05.005_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/carcin\/bgt004","article-title":"Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer","volume":"34","author":"Huang","year":"2013","journal-title":"Carcinogenesis"},{"issue":"30","key":"10.1016\/j.pan.2022.05.005_bib18","first-page":"3382","article-title":"Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma","volume":"35","author":"Shindo","year":"2017","journal-title":"J\u00a0Clin Orthod"},{"issue":"4","key":"10.1016\/j.pan.2022.05.005_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jamcollsurg.2017.12.021","article-title":"BRCA1\/BRCA2 germline mutation carriers and sporadic pancreatic ductal adenocarcinoma","volume":"226","author":"Blair","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"7","key":"10.1016\/j.pan.2022.05.005_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"Zhen","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.pan.2022.05.005_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","article-title":"The prevalence of BRCA2 mutations in familial pancreatic cancer","volume":"16","author":"Couch","year":"2007","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jnci\/95.3.214","article-title":"BRCA2 germline mutations in familial pancreatic carcinoma","volume":"95","author":"Hahn","year":"2003","journal-title":"JNCI J Nat Cancer Inst"},{"issue":"8","key":"10.1016\/j.pan.2022.05.005_bib23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/cncr.31242","article-title":"Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy: mutations in Selected Pancreatic Cancers","volume":"124","author":"Dudley","year":"2018","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.pan.2022.05.005_bib24","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin\u2013cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J\u00a0Natl Cancer Inst: J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.pan.2022.05.005_bib25","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/bjc.2012.483","article-title":"The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers","volume":"107","author":"Group","year":"2012","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.pan.2022.05.005_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cncr.26191","article-title":"Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer","volume":"118","author":"Stadler","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib27","first-page":"433","article-title":"BRCA germline mutations in jewish patients with pancreatic adenocarcinoma","volume":"27","author":"Ferrone","year":"2009","journal-title":"J\u00a0Clin Orthod"},{"issue":"28","key":"10.1016\/j.pan.2022.05.005_bib28","first-page":"3124","article-title":"Germline BRCA mutations in a large clinic-based cohort of patients with pancreatic adenocarcinoma","volume":"33","author":"Holter","year":"2015","journal-title":"J\u00a0Clin Orthod"},{"key":"10.1016\/j.pan.2022.05.005_bib29","series-title":"Cancer syndromes","article-title":"Familial atypical multiple mole melanoma syndrome","author":"Eckerle Mize","year":"2009"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00000658-200212000-00005","article-title":"CDKN2A germline mutations in familial pancreatic cancer","volume":"236","author":"Bartsch","year":"2002","journal-title":"Ann Surg"},{"issue":"15","key":"10.1016\/j.pan.2022.05.005_bib31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","article-title":"Increased risk of pancreatic cancer in melanoma-prone kindreds with p16 INK4 mutations","volume":"333","author":"Goldstein","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/bjc.1990.209","article-title":"Systemic cancer and the FAMMM syndrome","volume":"61","author":"Bergman","year":"1990","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.pan.2022.05.005_bib33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.139.8.1019","article-title":"Pancreatic carcinoma surveillance in patients with familial melanoma","volume":"139","author":"Parker","year":"2003","journal-title":"Arch Dermatol"},{"issue":"15","key":"10.1016\/j.pan.2022.05.005_bib34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","article-title":"High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families","volume":"92","author":"Borg","year":"2000","journal-title":"JNCI J Nat Cancer Inst"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13053-021-00178-x","article-title":"CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition","volume":"19","author":"Chan","year":"2021","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.pan.2022.05.005_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.837057","article-title":"Considerations for germline testing in melanoma: updates in behavioral change and pancreatic surveillance for carriers of CDKN2A pathogenic variants","volume":"12","author":"Pauley","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jmedgenet-2011-100563","article-title":"Indication for CDKN2A -mutation analysis in familial pancreatic cancer families without melanomas","volume":"49","author":"Harinck","year":"2012","journal-title":"J\u00a0Med Genet"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","article-title":"Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)","volume":"87","author":"Vasen","year":"2000","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-199506000-00005","article-title":"CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families","volume":"5","author":"Gruis","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1016\/j.pan.2022.05.005_bib40","series-title":"GeneReviews\u00ae","article-title":"Peutz-jeghers syndrome","author":"McGarrity","year":"1993"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4174\/astr.2014.86.6.325","article-title":"Peutz-Jeghers syndrome with germline mutation of STK11","volume":"86","author":"Chae","year":"2014","journal-title":"Ann Surg Treat Res"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib42","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":"High cancer risk in peutz\u2013jeghers syndrome: a systematic review and surveillance recommendations","volume":"105","author":"van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.pan.2022.05.005_bib43","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190099","article-title":"The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde? <sup\/>","volume":"9","author":"Vara-Ciruelos","year":"2019","journal-title":"Open Biol"},{"issue":"7","key":"10.1016\/j.pan.2022.05.005_bib44","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.febslet.2010.12.034","article-title":"Molecular mechanisms of tumor suppression by LKB1","volume":"585","author":"Vaahtomeri","year":"2011","journal-title":"FEBS (Fed Eur Biochem Soc) Lett"},{"issue":"2","key":"10.1016\/j.pan.2022.05.005_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/gim.2017.85","article-title":"Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history","volume":"20","author":"Chaffee","year":"2018","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2004.06.012","article-title":"No evidence for germline mutations of the LKB1\/STK11 gene in familial pancreatic carcinoma","volume":"214","author":"Gr\u00fctzmann","year":"2004","journal-title":"Cancer Lett"},{"issue":"31","key":"10.1016\/j.pan.2022.05.005_bib48","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i31.10778","article-title":"Genetic predisposition to pancreatic cancer","volume":"20","author":"Ghiorzo","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.pan.2022.05.005_bib49","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/1097-0142(19931101)72:9<2777::AID-CNCR2820720940>3.0.CO;2-6","article-title":"Cancer in peutz-jeghers syndrome","volume":"72","author":"Hizawa","year":"1993","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib50","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0002-9440(10)65440-5","article-title":"Germline and somatic mutations of the STK11\/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers","volume":"154","author":"Su","year":"1999","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.pan.2022.05.005_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jmg.2003.010900","article-title":"Genotype-phenotype correlations in Peutz-Jeghers syndrome","volume":"41","author":"Amos","year":"2004","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00384-009-0793-0","article-title":"Truncating mutations in Peutz-Jeghers syndrome are associated with more polyps, surgical interventions and cancers","volume":"25","author":"Salloch","year":"2010","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"10.1016\/j.pan.2022.05.005_bib53","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jmg.2004.026294","article-title":"STK11 genotyping and cancer risk in Peutz-Jeghers syndrome","volume":"42","author":"Schumacher","year":"2005","journal-title":"J\u00a0Med Genet"},{"issue":"7","key":"10.1016\/j.pan.2022.05.005_bib54","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1053\/j.gastro.2004.03.014","article-title":"Relative frequency and morphology of cancers in STK11 mutation carriers1","volume":"126","author":"Lim","year":"2004","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.pan.2022.05.005_bib55","first-page":"1070","article-title":"Deleterious germline mutations are a risk factor for neoplastic progression among high-risk individuals undergoing pancreatic surveillance","volume":"37","author":"Abe","year":"2019","journal-title":"J\u00a0Clin Orthod"},{"key":"10.1016\/j.pan.2022.05.005_bib56","series-title":"Lynch syndrome","author":"Bhattacharya","year":"2021"},{"key":"10.1016\/j.pan.2022.05.005_bib57","series-title":"GeneReviews\u00ae","article-title":"Lynch syndrome","author":"Idos","year":"1993"},{"issue":"11","key":"10.1016\/j.pan.2022.05.005_bib58","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.humpath.2006.06.024","article-title":"Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene","volume":"37","author":"Banville","year":"2006","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/genes12010033","article-title":"Immune-based therapies and the role of microsatellite instability in pancreatic cancer","volume":"12","author":"Ghidini","year":"2020","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.pan.2022.05.005_bib60","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1002\/cam4.2973","article-title":"Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening","volume":"9","author":"Cremin","year":"2020","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib61","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.gie.2017.12.019","article-title":"Pancreatic cancer screening in high-risk individuals with germline genetic mutations","volume":"87","author":"DaVee","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.pan.2022.05.005_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102675","article-title":"A\u00a0comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants","volume":"53","author":"Earl","year":"2020","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.pan.2022.05.005_bib63","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10689-009-9285-1","article-title":"Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome","volume":"8","author":"Gargiulo","year":"2009","journal-title":"Fam Cancer"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib64","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2014.11.042","article-title":"Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer","volume":"148","author":"Grant","year":"2015","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.pan.2022.05.005_bib65","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2009.1529","article-title":"Risk of pancreatic cancer in families with Lynch syndrome","volume":"302","author":"Kastrinos","year":"2009","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pan.2022.05.005_bib66","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/MPA.0b013e318220c217","article-title":"Pancreatic cancer and a novel MSH2 germline alteration","volume":"40","author":"Lindor","year":"2011","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000001617","article-title":"MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer","volume":"32","author":"Mannucci","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2022.05.005_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103033","article-title":"Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes","volume":"60","author":"Mizukami","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"24","key":"10.1016\/j.pan.2022.05.005_bib70","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.29664","article-title":"Identification of germline genetic mutations in patients with pancreatic cancer: germline Mutations in Pancreatic Cancer","volume":"121","author":"Salo-Mullen","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.pan.2022.05.005_bib71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41436-018-0009-5","article-title":"Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer","volume":"21","author":"Yurgelun","year":"2019","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.pan.2022.05.005_bib72","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1158\/1535-7163.MCT-19-0208","article-title":"ATM dysfunction in pancreatic adenocarcinoma and associated therapeutic implications","volume":"18","author":"Armstrong","year":"2019","journal-title":"Mol Cancer Therapeut"},{"issue":"45","key":"10.1016\/j.pan.2022.05.005_bib73","doi-asserted-by":"crossref","first-page":"74227","DOI":"10.18632\/oncotarget.12490","article-title":"Germline mutations in Japanese familial pancreatic cancer patients","volume":"7","author":"Takai","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.pan.2022.05.005_bib74","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1947601911413466","article-title":"Li-fraumeni syndrome","volume":"2","author":"Malkin","year":"2011","journal-title":"Genes Cancer"},{"issue":"11","key":"10.1016\/j.pan.2022.05.005_bib75","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jmb.2017.03.030","article-title":"Mutant p53 in cancer: accumulation, gain-of-function, and therapy","volume":"429","author":"Yue","year":"2017","journal-title":"J\u00a0Mol Biol"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2009.073429","article-title":"TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes","volume":"47","author":"Ruijs","year":"2010","journal-title":"J\u00a0Med Genet"},{"issue":"12","key":"10.1016\/j.pan.2022.05.005_bib77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.pan.2022.05.005_bib78","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/ajmg.a.34087","article-title":"How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel","volume":"155A","author":"Rosenberg","year":"2011","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pan.2022.05.005_bib79","series-title":"Fanconi anemia","author":"Bhandari","year":"2021"},{"issue":"7","key":"10.1016\/j.pan.2022.05.005_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067538","article-title":"Analysis of PALB2 gene in BRCA1\/BRCA2 negative Spanish hereditary breast\/ovarian cancer families with pancreatic cancer cases","volume":"8","author":"Blanco","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pan.2022.05.005_bib81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-017-0019-5","article-title":"The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes","volume":"17","author":"Clinical Cancer Genomics Community Research","year":"2018","journal-title":"Fam Cancer"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib82","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3892\/ol.2021.12485","article-title":"PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma","volume":"21","author":"Ge","year":"2021","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.pan.2022.05.005_bib83","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10689-011-9426-1","article-title":"PALB2 mutations in familial breast and pancreatic cancer","volume":"10","author":"Hofstatter","year":"2011","journal-title":"Fam Cancer"},{"issue":"10","key":"10.1016\/j.pan.2022.05.005_bib84","first-page":"2585","article-title":"Fanconi anemia gene mutations in young-onset pancreatic cancer","volume":"63","author":"van der Heijden","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.pan.2022.05.005_bib85","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1399-0004.2010.01425.x","article-title":"PALB2 mutations in European familial pancreatic cancer families","volume":"78","author":"Slater","year":"2010","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.pan.2022.05.005_bib86","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cancergen.2016.03.003","article-title":"Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic","volume":"209","author":"Borecka","year":"2016","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib87","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2010.10.015","article-title":"Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis","volume":"9","author":"Cot\u00e9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2022.05.005_bib88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/CEG.S84358","article-title":"Hereditary pancreatitis: current perspectives","volume":"9","author":"Willingham","year":"2016","journal-title":"CEG"},{"issue":"8","key":"10.1016\/j.pan.2022.05.005_bib89","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/humu.20343","article-title":"Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis","volume":"27","author":"Teich","year":"2006","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.pan.2022.05.005_bib90","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/89.6.442","article-title":"Hereditary pancreatitis and the risk of pancreatic cancer","volume":"89","author":"Lowenfels","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pan.2022.05.005_bib91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ebiom.2019.09.032","article-title":"Natural history of SPINK1 germline mutation related-pancreatitis","volume":"48","author":"Muller","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.pan.2022.05.005_bib92","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/00365520510011560","article-title":"Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland","volume":"40","author":"Lempinen","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.pan.2022.05.005_bib93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00006676-200404000-00018","article-title":"Hereditary pancreatitis as the premalignant disease: a Japanese case of pancreatic cancer involving the SPINK1 gene mutation N34S","volume":"28","author":"Masamune","year":"2004","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.pan.2022.05.005_bib94","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2012.05.001","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis","volume":"11","author":"Ooi","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"issue":"4","key":"10.1016\/j.pan.2022.05.005_bib95","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000348439","article-title":"Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants","volume":"87","author":"Hamoir","year":"2013","journal-title":"Digestion"},{"key":"10.1016\/j.pan.2022.05.005_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.24697","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma","author":"McWilliams","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2022.05.005_bib97","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semcancer.2020.08.003","article-title":"Germline genetic variability in pancreatic cancer risk and prognosis","volume":"79","author":"Gentiluomo","year":"2022","journal-title":"Semin Cancer Biol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390322001727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390322001727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T15:24:20Z","timestamp":1662737060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390322001727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1424390322001727"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2022.05.005","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}